Zealand Pharma A/S (CPH:ZEAL)
Denmark
· Delayed Price · Currency is DKK 255.80
+20.90 (8.90%)
At close: Mar 9, 2026
Zealand Pharma Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 16,586 | 32,852 | 50,548 | 21,785 | 10,366 | 6,271 | Upgrade
|
| Market Cap Growth | -70.04% | -35.01% | 132.03% | 110.16% | 65.31% | -28.46% | Upgrade
|
| Enterprise Value | 1,883 | 17,089 | 41,733 | 20,319 | 10,519 | 5,364 | Upgrade
|
| Last Close Price | 234.90 | 466.40 | 715.50 | 373.20 | 201.40 | 145.10 | Upgrade
|
| PE Ratio | 2.60 | 5.09 | - | - | - | - | Upgrade
|
| PS Ratio | 1.80 | 3.57 | 806.30 | 63.55 | 99.69 | 57.77 | Upgrade
|
| PB Ratio | 1.12 | 2.22 | 5.87 | 13.68 | 12.71 | 6.76 | Upgrade
|
| P/TBV Ratio | 1.12 | 2.22 | 5.88 | 13.78 | 12.71 | 7.17 | Upgrade
|
| P/FCF Ratio | 2.55 | 5.06 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 2.54 | 5.03 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 0.20 | 1.86 | 665.70 | 59.28 | 101.16 | 49.41 | Upgrade
|
| EV/EBITDA Ratio | 0.27 | 2.47 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 0.27 | 2.47 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 0.29 | 2.63 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.05 | 0.08 | 0.64 | 0.85 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.06 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.06 | 0.06 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.99 | -0.99 | -1.00 | -0.95 | -0.80 | -0.69 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.12 | -2.12 | 6.88 | 2.73 | 0.90 | 0.83 | Upgrade
|
| Net Debt / FCF Ratio | -2.26 | -2.26 | 9.20 | 3.47 | 0.69 | 0.52 | Upgrade
|
| Asset Turnover | 0.72 | 0.72 | 0.01 | 0.20 | 0.06 | 0.06 | Upgrade
|
| Inventory Turnover | - | - | 0.85 | 0.69 | - | 0.12 | Upgrade
|
| Quick Ratio | 23.20 | 23.20 | 20.85 | 6.23 | 6.73 | 4.80 | Upgrade
|
| Current Ratio | 23.57 | 23.57 | 21.14 | 6.25 | 6.73 | 5.15 | Upgrade
|
| Return on Equity (ROE) | 55.06% | 55.06% | -21.13% | -58.43% | -110.75% | -69.99% | Upgrade
|
| Return on Assets (ROA) | 33.97% | 33.97% | -13.81% | -19.93% | -28.30% | -25.53% | Upgrade
|
| Return on Invested Capital (ROIC) | - | 1401.57% | -294.62% | -465.46% | -363.56% | -402.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 45.30% | 45.30% | -13.90% | -33.10% | -60.70% | -45.10% | Upgrade
|
| Earnings Yield | 38.92% | 19.65% | -2.13% | -3.23% | -11.60% | -16.24% | Upgrade
|
| FCF Yield | 39.18% | 19.78% | -1.86% | -2.01% | -9.20% | -19.68% | Upgrade
|
| Buyback Yield / Dilution | -7.70% | -7.70% | -17.40% | -22.49% | -7.77% | -11.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.